The Latest Cardiac and Vascular News
DUBLIN, Ireland and BRIDGEWATER, N.J., May 21, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), today announced support for a clinical trial to investigate the effects of icosapent ethyl (IPE) (VASCEPA®) on inflammatory biomarkers and other patient outcomes in individuals with COVID-19. The trial is sponsored by the Canadian Medical and […]
Coronary Advanced to Help Fellows and Attending Interventional Cardiologists to Perfect Skills in Complex Scenarios STOCKHOLM, May 21, 2020 /PRNewswire/ — Mentice AB (STO: MNTC), a world leader in high-fidelity endovascular simulation introduces Coronary Advanced for select VIST® platforms. Following the introduction of Coronary Essentials and Coronary Intermediate, Coronary Advanced is the most […]
Women Disproportionately Impacted with Bailout DANVERS, Mass.–(BUSINESS WIRE)–Data from more than 1,000 patients presented during the virtual 2020 Society for Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions demonstrates Impella reduced in-hospital mortality when placed before a non-emergent percutaneous coronary intervention (PCI) is performed. As detailed in the online presentation, the research found, in […]
Mezzion Pharma files new patent applications to cover globally this important MPI advancement, a unique new finding as a result of treatment of SVHD patients with udenafil SEOUL, South Korea, May 18, 2020 /PRNewswire/ — Mezzion Pharma Co. Ltd. today announced that analysis of data from its Phase 3 FUEL trial showed statistically significant positive […]
Clinical evidence shows significant patient radiation reduction with CorPath® GRX Vascular Robotic System WALTHAM, Mass.–(BUSINESS WIRE)–Corindus, a Siemens Healthineers Company and leading developer of precision vascular robotics, announced today that Circulation: Cardiovascular Interventions has published clinical results from a comparative study between robotic percutaneous coronary intervention (PCI) and manual PCI. Findings from the study […]
Milestone Results Presented as Late-Breaking Clinical Science at SCAI 2020 DUBLIN, May 15, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) today announced results from two late-breaking clinical trials presented virtually at the 2020 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions. Ten-year outcomes from the Melody™ Transcatheter Pulmonary Valve (TPV) Therapy […]
IRVINE, Calif., May 18, 2020 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received CE Mark for the Edwards PASCAL transcatheter valve repair system for the treatment of European patients with tricuspid regurgitation (TR). “Although the […]
Recardio Inc., a life science company developing regenerative therapies for cardiovascular diseases, announced publication of the outcomes of the Phase 1 clinical trial of its lead candidate dutogliptin. Entitled “Safety, tolerability, pharmacokinetics, and pharmacodynamics of parenterally administered dutogliptin: A prospective dose escalating trial”, the article can be accessed here: https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.14208 […]
Single administration of CLBS16 durably improves heart function and symptoms in patients with coronary microvascular dysfunction BASKING RIDGE, N.J., May 14, 2020 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, […]
First and total coronary revascularization event reductions of 34% and 36%, respectively, shown with VASCEPA in prespecified tertiary endpoint analyses Results of prespecified tertiary endpoint analyses consistent across different types of coronary revascularization procedures, including urgent, emergent, and elective interventions Percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) […]
